HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognosis and risk stratification of young adults with Brugada syndrome.

Abstract
Prognosis and risk factors for patients age 35years or younger with Brugada syndrome (BrS) were prospectively explored in a sub-analysis of the Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) registry. During the period from February 2002 to January 2011, 69 cases (mean age 30±6years, male=66) of the young (at or less than 35years old) BrS were enrolled in J-IVFS and the clinical course was followed for more than 1year. They were divided into 3 groups: documented ventricular fibrillation (VF) or aborted sudden cardiac death (SCD) (VF group, 12 cases), syncope without documentation of VF (Syncope group, 17 cases) and asymptomatic group (Asympt. group, 40 cases). During a mean follow-up period of 43±27months, cardiac events (VF and/or SCD) developed in 8 cases, with 5 of 12 cases in the VF (41.7%), 2 of 17 cases in the Syncope (11.8%) and 1 of 40 cases in the Asympt. group (2.5%). The VF group had a worse prognosis for cardiac events than the Syncope and Asympt. group. Multivariate analysis revealed symptoms as a risk factor for predicting cardiac events.
AuthorsMasayasu Hiraoka, Masahiko Takagi, Yasuhiro Yokoyama, Yukio Sekiguchi, Naohiko Aihara, Kazutaka Aonuma, Japan Idiopathic Ventricular Fibrillation Study Investigators
JournalJournal of electrocardiology (J Electrocardiol) Vol. 46 Issue 4 Pg. 279-83 ( 2013) ISSN: 1532-8430 [Electronic] United States
PMID23702150 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Topics
  • Adolescent
  • Adult
  • Age Distribution
  • Brugada Syndrome (diagnosis, mortality)
  • Causality
  • Comorbidity
  • Death, Sudden, Cardiac (epidemiology)
  • Electrocardiography (statistics & numerical data)
  • Female
  • Humans
  • Incidence
  • Japan (epidemiology)
  • Male
  • Middle Aged
  • Prognosis
  • Risk Factors
  • Survival Rate
  • Syncope (diagnosis, mortality)
  • Ventricular Fibrillation (diagnosis, mortality)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: